Cargando…
Treating hypoxemic COVID-19 “ARDS” patients with almitrine: The earlier the better?
Autores principales: | Bendjelid, Karim, Giraud, Raphael, Von Düring, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347339/ https://www.ncbi.nlm.nih.gov/pubmed/32653550 http://dx.doi.org/10.1016/j.accpm.2020.07.003 |
Ejemplares similares
-
Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology
por: Bendjelid, Karim, et al.
Publicado: (2020) -
Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19
por: Laghlam, Driss, et al.
Publicado: (2021) -
Acute Cor Pulmonale in COVID-19-Related ARDS: Improvement With Almitrine Infusion
por: Huette, Pierre, et al.
Publicado: (2020) -
COVID-19: desperate times call for desperate measures
por: von Düring, Stephan, et al.
Publicado: (2020) -
Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trial
por: Kalfon, Pierre, et al.
Publicado: (2022)